These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 2452133)
1. Further studies on the heterogeneity of antigens recognised by CD-1 monoclonal antibodies: distribution of epitopes and analysis of serological binding patterns. Favaloro EJ; Bradstock KF; Grimsley A; Henniker A; Kamath S Immunol Cell Biol; 1987 Dec; 65 ( Pt 6)():517-27. PubMed ID: 2452133 [TBL] [Abstract][Full Text] [Related]
2. Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and non-haemopoietic distribution using panels of monoclonal antibodies belonging to CD-11b, CD-13 and CD-33. Favaloro EJ; Bradstock KF; Kabral A; Grimsley P; Zowtyj H; Zola H Br J Haematol; 1988 Jun; 69(2):163-71. PubMed ID: 2455535 [TBL] [Abstract][Full Text] [Related]
3. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb. Rebai N; Malissen B; Pierres M; Accolla RS; Corte G; Mawas C Eur J Immunol; 1983 Feb; 13(2):106-11. PubMed ID: 6187579 [TBL] [Abstract][Full Text] [Related]
4. Delineation of three subsets of class I human T antigens (HTA) on Molt-4 cells: serologic and regulatory relationship to HLA class I antigens. Kahn-Perles B; Wietzerbin J; Caillol DH; Lemonnier F J Immunol; 1985 Mar; 134(3):1759-65. PubMed ID: 2578520 [TBL] [Abstract][Full Text] [Related]
5. The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation. Osorio LM; Garcia CA; Jondal M; Chow SC Cell Immunol; 1994 Mar; 154(1):123-33. PubMed ID: 7509726 [TBL] [Abstract][Full Text] [Related]
6. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. van Lier RA; Borst J; Vroom TM; Klein H; Van Mourik P; Zeijlemaker WP; Melief CJ J Immunol; 1987 Sep; 139(5):1589-96. PubMed ID: 2442250 [TBL] [Abstract][Full Text] [Related]
7. Anti-CD23 monoclonal antibodies: comparisons of epitope specificities and modulating capacities for IgE binding and production. Wakai M; Pasley P; Sthoeger ZM; Posnett DN; Brooks R; Hashimoto S; Chiorazzi N Hybridoma; 1993 Feb; 12(1):25-43. PubMed ID: 7681036 [TBL] [Abstract][Full Text] [Related]
8. Distinct epitopes on the T cell antigen receptor of HPB-ALL tumor cells identified by monoclonal antibodies. Lanier LL; Ruitenberg JJ; Allison JP; Weiss A J Immunol; 1986 Oct; 137(7):2286-92. PubMed ID: 2428866 [TBL] [Abstract][Full Text] [Related]
9. Isoforms of the E2 molecule: D44 monoclonal antibody defines an epitope on E2 and reacts differentially with T cell subsets. Gelin C; Zoccola D; Valentin H; Raynal B; Bernard A Eur J Immunol; 1991 Mar; 21(3):715-9. PubMed ID: 1707004 [TBL] [Abstract][Full Text] [Related]
10. A novel T cell-activating molecule (THAM) highly expressed on CD4-CD8- murine thymocytes. Naquet P; MacDonald HR; Brekelmans P; Barbet J; Marchetto S; Van Ewijk W; Pierres M J Immunol; 1988 Dec; 141(12):4101-9. PubMed ID: 2461984 [TBL] [Abstract][Full Text] [Related]
11. Triggering CD 28 molecules synergize with CD 2 (T 11.1 and T 11.2)-mediated T cell activation. Pierrès A; Lopez M; Cerdan C; Nunes J; Olive D; Mawas C Eur J Immunol; 1988 May; 18(5):685-90. PubMed ID: 2454190 [TBL] [Abstract][Full Text] [Related]
12. Production and characterization of a monoclonal antibody specific for the human lymphocyte low affinity receptor for IgE: CD 23 is a low affinity receptor for IgE. Bonnefoy JY; Aubry JP; Peronne C; Wijdenes J; Banchereau J J Immunol; 1987 May; 138(9):2970-8. PubMed ID: 2952729 [TBL] [Abstract][Full Text] [Related]
13. Anti-interleukin 2 receptor monoclonal antibodies. Respective role of epitope mapping and monoclonal antibody-receptor interactions in their antagonist effects on interleukin 2-dependent T cell growth. Olive D; Raymond J; Dubreuil P; Charmot D; Jacques Y; Mawas C Eur J Immunol; 1986 Jun; 16(6):611-6. PubMed ID: 2424766 [TBL] [Abstract][Full Text] [Related]
14. Idiotypic analysis of anti-I-Ak monoclonal antibodies. II. Detection of shared idiotopes on syngeneic BALB/c and allogeneic A.TH-derived anti-I-Ak mAb by BALB/c-derived anti-I-Ak anti-idiotypic mAb. Devaux CA; Phillips ML; Delovitch TL J Immunol; 1984 Nov; 133(5):2595-602. PubMed ID: 6207236 [TBL] [Abstract][Full Text] [Related]
16. Anti-CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation. I. Pairs of anti-T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12-O-tetradecanoylphorbol 13-acetate. Olive D; Ragueneau M; Cerdan C; Dubreuil P; Lopez M; Mawas C Eur J Immunol; 1986 Sep; 16(9):1063-8. PubMed ID: 2428622 [TBL] [Abstract][Full Text] [Related]
17. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies. Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the Thy-1 pathway of T cell hybridoma activation using 17 rat monoclonal antibodies reactive with distinct Thy-1 epitopes. Pont S; Regnier-Vigouroux A; Naquet P; Blanc D; Pierres A; Marchetto S; Pierres M Eur J Immunol; 1985 Dec; 15(12):1222-8. PubMed ID: 2417861 [TBL] [Abstract][Full Text] [Related]
19. Antigenic subtyping and epitopes' competition analysis of porcine circovirus type 2 using monoclonal antibodies. Saha D; Huang L; Bussalleu E; Lefebvre DJ; Fort M; Van Doorsselaere J; Nauwynck HJ Vet Microbiol; 2012 May; 157(1-2):13-22. PubMed ID: 22176764 [TBL] [Abstract][Full Text] [Related]
20. Structure-function relationship and immunochemical mapping of external and intracellular antigenic sites on the lymphocyte activation inducer molecule, AIM/CD69. Sánchez-Mateos P; Sánchez-Madrid F Eur J Immunol; 1991 Oct; 21(10):2317-25. PubMed ID: 1717281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]